Life-Threatening Hemopericardium Associated with Rivaroxaban
Joint Authors
Poudel, Dilli
Dhital, Rashmi
Basnet, Sijan
Tharu, Biswaraj
Tachamo, Niranjan
Ghimire, Sushil
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-04-05
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Rivaroxaban is a novel oral anticoagulant used in the treatment of venous thromboembolism.
The use of this medication has expanded over the recent years with resultant expansion of side effect profile.
We present a case of a 56-year-old female who presented with shortness of breath and chest pain 12 weeks after starting rivaroxaban for left upper extremity deep vein thrombosis.
She was later diagnosed with spontaneous hemopericardium requiring pericardial fluid drainage.
Rarer side effects like this will be encountered more often with the increasing use of novel oral anticoagulants.
The clinicians should be cognizant of this entity among patients with shortness of breath and chest pain for timely diagnosis and intervention.
American Psychological Association (APA)
Basnet, Sijan& Tachamo, Niranjan& Tharu, Biswaraj& Dhital, Rashmi& Ghimire, Sushil& Poudel, Dilli. 2017. Life-Threatening Hemopericardium Associated with Rivaroxaban. Case Reports in Cardiology،Vol. 2017, no. 2017, pp.1-3.
https://search.emarefa.net/detail/BIM-1144063
Modern Language Association (MLA)
Basnet, Sijan…[et al.]. Life-Threatening Hemopericardium Associated with Rivaroxaban. Case Reports in Cardiology No. 2017 (2017), pp.1-3.
https://search.emarefa.net/detail/BIM-1144063
American Medical Association (AMA)
Basnet, Sijan& Tachamo, Niranjan& Tharu, Biswaraj& Dhital, Rashmi& Ghimire, Sushil& Poudel, Dilli. Life-Threatening Hemopericardium Associated with Rivaroxaban. Case Reports in Cardiology. 2017. Vol. 2017, no. 2017, pp.1-3.
https://search.emarefa.net/detail/BIM-1144063
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1144063